Global Regulatory Affairs Outsourcing Market: Analyst’s Estimations

Economic and competitive pressures in the healthcare industry continue to motivate life sciences companies to explore ways of cutting costs across operations and increase their focus on product innovations, research activities, and improved turnaround time of deliverables. Companies aspiring to widen their global reach are increasing investments on R&D activities and new products are entering clinical trials and the market at a rapid pace. Undertaking regulatory affairs and the maintenance of vast volumes data generated during the process can be a daunting task for companies having a vast product portfolio and operations spread across diverse regional markets.

These factors have encouraged an increased rate of outsourcing of regulatory affairs across life sciences industries in the past few years. Recent findings by Transparency Market Research state that the global regulatory affairs outsourcing market will exhibit a healthy 10.1% CAGR from 2017 to 2023. As a result, the market, which had a valuation of US$3,234.4 million in 2017 will rise to US$5,746.5 million by 2023.

global regulatory affairs outsourcing market

Clinical Trial Application and Product Registration Services to be Key Enabler of Growth

Of the key regulatory affair services outsourced by life sciences companies, regulatory writing and publishing is presently the largest market segment, accounting for a share of more than 43% across the global market in 2017. Owing to the diverse and continuously changing regulations across local, regional, national, and international markets, companies spend a vast share in their overall regulatory investments for timely updating data such as regulatory submissions and standard operating procedures. It is owing to this fact that the segment of regulatory writing and publishing leads the regulatory affairs outsourcing market. By the end of 2023, this segment is estimated to be worth US$2,406.6 million.

Over the next few years, however, the market for regulatory affairs outsourcing is witness the highest gains from the clinical trial applications and product registration segment. Factors such as patent expiries and the rising prevalence of a number of chronic, viral, and bacterial diseases have prompted biopharmaceutical companies in the development of a large number of new products. With the rising number of products in clinical trials, the demand for clinical trial application and product registration services is expected to substantially rise in the next few years.

Low-cost Clinical Trial Centers in Emerging Economies to be Key Enabler of Growth

In the years to come, regulatory affairs service providers in emerging economies across regions such as Latin America and Asia Pacific are expected to bag the most numbers of outsourcing projects across the globe. An increased number of biopharmaceutical companies are using emerging economies as a launch pad for their venture in larger markets such as North America and Europe.

Product development, research, and commercialization units are being set up at an increased rate across emerging economies owing to cheap resources and raw material costs. The vast population base of Asia Pacific also makes it a lucrative regional market for the medical industry. These factors are acting in favor of the regulatory affairs outsourcing markets in these regions and will help strengthen the market’s foothold in the next few years. As a result, the market for regulatory affairs outsourcing market in emerging economies will offer the most lucrative and sustained growth opportunities for the global market. The market is expected to expand at a 14.1% CAGR in Asia Pacific and 9.6% CAGR across Latin America from 2017 to 2023.

Global Regulatory Affairs Outsourcing Market: Overview

This research study analyzes the market for regulatory affairs outsourcing services in terms of revenue (US$ Mn). The stakeholders of this report comprises the clinical research organizations. The global regulatory affairs outsourcing market has been broadly segmented on the basis of services (Regulatory Submissions, Clinical Trial Applications and Product Registrations, Regulatory Writing and Publishing, Regulatory Consulting and Legal Representation and others regulatory affairs, and Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). 

Each geographic region is further analyzed at the country level for regulatory affairs outsourcing market. The market for each of these segment has been analyzed on the basis of various market dynamics such as technological advances, its advantages and increasing use of outsourcing by leading pharmaceutical and biotechnology companies. Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2017 to 2023 are provided for all the segments, considering 2016 as the base year.

Global Regulatory Affairs Outsourcing Market: Key Research Aspects

The regulatory affairs outsourcing market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities affecting the demand and acceptance of outsourcing regulatory affairs activities across the globe. The report provides a detailed industry analysis of the global regulatory affairs outsourcing market with the help of Porter’s Five Forces model which pose an impact on the sustainability of the companies and value chain analysis.

The forces analyzed are bargaining power of buyers, bargaining power of suppliers, threat of new entrants, threat of substitutes, and degree of competition. The market attractiveness analysis has been provided in the market overview section in order to elucidate the intensity of competition in the market in different regions across the globe. The competitive scenario between different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares worldwide.

A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market.

Global Regulatory Affairs Outsourcing Market: Company Profiles

The report also profiles major players in the this market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Key players in the global regulatory affairs outsourcing market are Criterium, Inc., Covance, Inc., Clinilabs, Inc., Charles River Laboratories International, Inc., and Accell Clinical Research, LLC.

The global regulatory affairs outsourcing market is segmented into the following categories:

By Services

  • Regulatory Submissions
  • Clinical Trial Applications and Product Registrations
  • Regulatory Writing and Publishing
  • Regulatory Consulting and Legal Representation
  • Other Regulatory Affairs

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific (APAC)
    • India
    • China
    • Japan
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and Africa (MEA)
    • South Africa
    • Rest of MEA 

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.


1. Preface

2. Executive Summary
    2.1. Global Regulatory Affairs Outsourcing Market Share, by Geography, 2014-2023 (US $ Mn)
    2.2. Global Regulatory Affairs Outsourcing Market, by Services, 2014 (US$ Mn)
    2.3. Global Regulatory Affairs Outsourcing: Market Snapshot

3. Industry Analysis: Global Regulatory Affairs Outsourcing Market 
    3.1. Introduction
    3.2. Market Drivers
           3.2.1. Driver 1: Increasing research and development activities across the world
           3.2.2. Driver 2: Increasing cost efficiencies
           3.2.3. Driver 3: Extensive documentation during drug/device manufacturing
    3.3. Market Restraints
           3.3.1. Restraint 1: Risk associated with data security, system access and loss of control
           3.3.2. Restraint 2: Technological advances leading to rapid pricing fluctuations
    3.4. Market Opportunities
           3.4.1. Opportunity 1: Emerging economies to offer lucrative growth opportunities
    3.5. Porter’s Five Forces Analysis
    3.6. Value Chain Analysis: Global Regulatory Affairs Outsourcing Market 
    3.7. Market Attractiveness Analysis– Regulatory Affairs Outsourcing Market, by Geography (2014) (%) 
    3.8. Competitive Landscape- Regulatory Affairs Outsourcing Market, by Key Players (2014) (%) 

4. Global Regulatory Affairs Outsourcing Market Segmentation – by Services
    4.1. Introduction
    4.2. Global Regulatory Affairs Outsourcing Market Revenue, by Services 2013–2023 (US$ Mn)
    4.3. Global Regulatory Submissions Market Revenue, 2013–2023, (US$ Mn)
    4.4. Global Clinical Trial Application and Product Registration Market Revenue, 2013–2023, (US$ Mn)
    4.5. Global Regulatory Writing and Publishing Market Revenue, 2013–2023, (US$ Mn)
    4.6. Global Regulatory Consultation and legal Representation Market Revenue, 2013–2023, (US$ Mn)
    4.7. Global Others Regulatory Affairs Market Revenue, 2013–2023, (US$ Mn)

5. Global Regulatory Affairs Outsourcing Market Segmentation – by Geography
    5.1. Introduction
    5.2. Global Regulatory Affairs Outsourcing Market Revenue, by Geography, 2013–2023 (US$ Mn)
    5.3. North America Regulatory Affairs Outsourcing Market Revenue, 2013–2023 (US$ Mn)
           5.3.1. U.S. Regulatory Affairs Outsourcing Market Revenue, 2013-2023 (US$Mn)
           5.3.2. Canada Regulatory Affairs Outsourcing Market Revenue, 2013-2023 (US$Mn)
    5.4. Europe Regulatory Affairs Outsourcing Market Revenue, 2013–2023 (US$ Mn)
           5.4.1. U.K. Regulatory Affairs Outsourcing Market Revenue, 2013-2023 (US$Mn)
           5.4.2. Germany Regulatory Affairs Outsourcing Market Revenue, 2013-2023 (US$Mn)
           5.4.3. Rest of Europe Regulatory Affairs Outsourcing Market Revenue, 2013-2023 (US$Mn)
    5.5. Asia Pacific (APAC) Regulatory Affairs Outsourcing Market Revenue, 2013–2023 (US$ Mn)
           5.5.1. India Regulatory Affairs Outsourcing Market Revenue, 2013–2023 (US$ Mn)
           5.5.2. China Regulatory Affairs Outsourcing Market Revenue, 2013–2023 (US$ Mn)
           5.5.3. Japan Regulatory Affairs Outsourcing Market Revenue, 2013–2023 (US$ Mn)
           5.5.4. Rest of APAC Regulatory Affairs Outsourcing Market Revenue, 2013–2023 (US$ Mn)
    5.6. Latin America (LATAM) Regulatory Affairs Outsourcing Market Revenue, 2013–2023 (US$ Mn)
           5.6.1. Brazil Regulatory Affairs Outsourcing Market Revenue, 2013-2023 (US$ Mn)
           5.6.2. Mexico Regulatory Affairs Outsourcing Market Revenue, 2013-2023 (US$ Mn)
           5.6.3. Rest of LATAM Regulatory Affairs Outsourcing Market Revenue, 2013-2023 (US$ Mn)
    5.7. Middle East and Africa (MEA) Regulatory Affairs Outsourcing Market Revenue, 2013–2023 (US$ Mn)
           5.7.1. South Africa Regulatory Affairs Outsourcing Market Revenue, 2013–2023 (US$ Mn)
           5.7.2. Rest of MEA Regulatory Affairs Outsourcing Market Revenue, 2013–2023 (US$ Mn)

6. Recommendations

7. Company Profiles
    7.1. Accell Clinical Research, LLC
           7.1.1. Company Overview
           7.1.2. Financial Overview
           7.1.3. Product Portfolio
           7.1.4. Business Strategies
           7.1.5. Recent Developments
    7.2. Charles River Laboratories International, Inc.
           7.2.1. Company Overview
           7.2.2. Financial Overview
           7.2.3. Product Portfolio
           7.2.4. Business Strategies
           7.2.5. Recent Developments
    7.3. Clinilabs, Inc.
           7.3.1. Company Overview
           7.3.2. Financial Overview
           7.3.3. Product Portfolio
           7.3.4. Business Strategies
           7.3.5. Recent Developments
    7.4. Covance, Inc. 
           7.4.1. Company Overview
           7.4.2. Financial Overview
           7.4.3. Product Portfolio
           7.4.4. Business Strategies
           7.4.5. Recent Developments
    7.5. Criterium, Inc.
           7.5.1. Company Overview
           7.5.2. Financial Overview
           7.5.3. Product Portfolio
           7.5.4. Business Strategies
           7.5.5. Recent Developments
    7.6. ICON plc
           7.6.1. Company Overview
           7.6.2. Financial Overview
           7.6.3. Product Portfolio
           7.6.4. Business Strategies
           7.6.5. Recent Developments
    7.7. Medpace, Inc.
           7.7.1. Company Overview
           7.7.2. Financial Overview
           7.7.3. Product Portfolio
           7.7.4. Business Strategies
           7.7.5. Recent Developments
    7.8. PAREXEL International Corporation
           7.8.1. Company Overview
           7.8.2. Financial Overview
           7.8.3. Product Portfolio
           7.8.4. Business Strategies
           7.8.5. Recent Developments
    7.9. Pharmaceutical Product Development, (PPD) LLC 
           7.9.1. Company Overview
           7.9.2. Financial Overview
           7.9.3. Product Portfolio
           7.9.4. Business Strategies
           7.9.5. Recent Developments
    7.10. Promedica International
           7.10.1. Company Overview
           7.10.2. Financial Overview
           7.10.3. Product Portfolio
           7.10.4. Business Strategies
           7.10.5. Recent Developments
    7.11. Quintiles Transnational Corporation
           7.11.1. Company Overview
           7.11.2. Financial Overview
           7.11.3. Product Portfolio
           7.11.4. Business Strategies
           7.11.5. Recent Developments
    7.12. WuXi App Tec
           7.12.1. Company Overview
           7.12.2. Financial Overview
           7.12.3. Product Portfolio
           7.12.4. Business Strategies
           7.12.5. Recent Developments

 

List of Tables

TABLE 1 Market Snapshot: Global Regulatory Affairs Outsourcing Market, 2014 and 2023
TABLE 2 Percentage of Registered Studies by Location 
TABLE 3 Share of Total Global R&D Spending
TABLE 4 Global Regulatory Affairs Outsourcing Market Revenue, by Services, 2013 – 2023 (US$ Mn)
TABLE 5 Global Regulatory Affairs Outsourcing Market Revenue, by Geography, 2013 – 2023 (US$ Mn)
TABLE 6 North America Regulatory Affairs Outsourcing Market Revenue, by Country, 2013 – 2023 (US$ Mn)
TABLE 7 Europe Regulatory Affairs Outsourcing Market Revenue, by Country, 2013 – 2023 (US$ Mn)
TABLE 8 Asia Pacific Regulatory Affairs Outsourcing Market Revenue, by Country, 2013 – 2023 (US$ Mn)
TABLE 9 Latin America Regulatory Affairs Outsourcing Market Revenue, by Country, 2013 – 2023 (US$ Mn)
TABLE 10 Middle East and Africa Regulatory Affairs Outsourcing Market Revenue, by Country, 2013 – 2023 (US$ Mn) 

 

List of Figures

FIGURE 1 Market Segmentation: Regulatory Affairs Outsourcing Market
FIGURE 2 Global Regulatory Affairs Outsourcing Market Share, by Geography, 2014 and 2023 (Value %)
FIGURE 3 Global Regulatory Affairs Outsourcing Market, by Services, (US$ Mn) 2014
FIGURE 4 Porter’s Five Forces Analysis: Regulatory Affairs Outsourcing Market
FIGURE 5 Value Chain Analysis: Regulatory Affairs Outsourcing Market
FIGURE 6 Market Attractiveness Analysis: Regulatory Affairs Outsourcing Market
FIGURE 7 Competitive Landscape: Regulatory Affairs Outsourcing Market
FIGURE 8 Global Outsourcing of Regulatory Submissions Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 9 Global Outsourcing of Clinical Trial Application & Product Registration Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 10 Global Outsourcing of Regulatory Writing and Publishing Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 11 Global Outsourcing of Regulatory Consulting & Legal Representation Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 12 Global Outsourcing of Other Regulatory Affairs Services Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 13 Charles River Laboratories International, Inc.: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 14 Covance, Inc.: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 15 ICON plc: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 16 PAREXEL International Corporation: Financial Overview, 2013 – 2015 (US$ Mn)    
FIGURE 17 Quintiles Transnational Corporation: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 18 Wuxi AppTec: Financial Overview, 2011 – 2013 (US$ Mn)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Global Regulatory Affairs Outsourcing Market